e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Respiratory physiology in health and disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Change in lung clearance index (LCI) following intravenous antibiotic intervention in children with CF
E. Scrase, C. Oliver, W. Kozlowska, J. Stocks, P. Aurora (London, United Kingdom)
Source:
Annual Congress 2008 - Respiratory physiology in health and disease
Session:
Respiratory physiology in health and disease
Session type:
Oral Presentation
Number:
3014
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Scrase, C. Oliver, W. Kozlowska, J. Stocks, P. Aurora (London, United Kingdom). Change in lung clearance index (LCI) following intravenous antibiotic intervention in children with CF. Eur Respir J 2008; 32: Suppl. 52, 3014
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Long-term lung clearance index (LCI) monitoring in young children with CF
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Year: 2007
Variability of the lung clearance index (LCI) assessed pre and post physiotherapy in patients with cystic fibrosis (CF)
Source: Annual Congress 2008 - Clinical applications of ventilatory function tests in paediatric pulmonology
Year: 2008
Longitudinal performance of the bronchiectasis severity index (BSI) in patients on regular intravenous (IV) antibiotic therapy for bronchiectasis
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Nebulised antibiotics with the I-neb adaptive aerosol delivery (AAD) system: Impact on adherence in cystic fibrosis (CF) patients
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012
Scond may better discriminate severe therapy resistant asthma (STRA) from mild-moderate asthma than lung clearance index (LCI)
Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease
Year: 2016
Is alveolar lung clearance index more sensitive than standard lung clearance index in preschool children?
Source: Annual Congress 2010 - Functional assessment of paediatric lung disease
Year: 2010
Lung clearance index (LCI) during the first years of life in children with CF
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
Lung clearance index (LCI) and nutritional parameters in infants with cystic fibrosis
Source: Annual Congress 2010 - Advances in lung function from infancy to adolescence
Year: 2010
Lung clearance index (LCI) using nitrogen washout in children with cystic fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 33s
Year: 2007
Lung clearance index: assessment and utility in children with asthma
Source: Eur Respir Rev, 28 (154) 190046; 10.1183/16000617.0046-2019
Year: 2019
A randomised comparison of two tobramycin formulations in cystic fibrosis (CF) patients with chronic
pseudomonas aeruginosa
(PA) infection for pharmacokinetic and therapeutic equivalence
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013
Investigation of shortened lung clearance index (LCI) in the Bronch-UK Clinimetrics study.
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018
Lung clearance index in paediatric exercise induced asthma
Source: Annual Congress 2012 - New understanding of childhood lung disease through physiological measurement
Year: 2012
Lung clearance index (LCI) and hyperinflation in children with cystic fibrosis (CF)
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012
Reporting specific airway resistance (sRaw) in children: mean or median?
Source: Annual Congress 2006 - Landmark developments in lung function testing: 2006
Year: 2006
Ventilation inhomogeneity (VI) and spirometry in response to intravenous antibiotics (IVab) in cystic fibrosis (CF)
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Lung clearance index (LCI) in pulmonary disease and healthy controls – can fewer measurements eventually be more?
Source: International Congress 2017 – Innovation in COPD: techniques and facts
Year: 2017
Addressing current gaps in the clinical utility of lung clearance index (LCI) in school aged children with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Lung clearance index and exercise capacity among children with bronchiectasis
Source: Annual Congress 2012 - New understanding of childhood lung disease through physiological measurement
Year: 2012
Is impulse oscillometry (IOS) better than spirometry for monitoring treatment outcomes in adult cystic fibrosis (CF) pulmonary exacerbations? A pilot study
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept